Scientific Overview A synthetic 13-amino acid linear melanocortin analog studied for receptor binding affinity, melanin production pathways, and signaling activity in research models
Providing GLP-1 drugs to 19.7 million Medicare beneficiaries with obesity would cost $268 billion a year, researchers estimate in a recent study
Myth: Peptides and Cancer Risk One of the first questions people ask is about the link between peptides and cancer
Half-life, StatPearls (2023) Semaglutide, StatPearls (2024) Drug elimination, StatPearls (2023) Antidotes, Medscape Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system, Frontiers in Public Health (2022) Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension, Diabetes, Obesity, and Metabolism (2022) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice